Amarin outlines accelerated path to positive free cash flow in 2026 supported by Recordati partnership and $70M OpEx savings
Source: SeekingAlpha
2025-10-29 10:22:29 ET
More on Amarin
- Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript
- Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom
- Amarin NON-GAAP EPS of 0.19 revenue of $49.7M beats by $6.6M
- Amarin Q3 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Amarin
Read the full article on Seeking Alpha
For further details see:
Amarin outlines accelerated path to positive free cash flow in 2026 supported by Recordati partnership and $70M OpEx savings
Amarin Corporation plc
NASDAQ: AMRN
AMRN Trading
-1.67% G/L:
$15.34 Last:
10,725 Volume:
$15.72 Open:
AMRN Latest News
March 07, 2026 01:35:00 am
Here's Why I Wouldn't Touch Amarin With a 10?Foot Pole Given Its Patent and Competition Risks
AMRN Stock Data
$312,618,004
18,426,477
1.2%
30
N/A
Pharmaceuticals
Healthcare
IE
Dublin 2
